Market
Synopsis of Global Mitochondrial Myopathies Market:
Market
scenario:
Considering
all these factors the market for mitochondrial myopathies is expected to reach
$ 600 million by the end of 2023, this market is projected to growing at a CAGR
of ~ 3.2 % during 2017-2023.
Mitochondrial myopathy is a rare mutational disease
and at present there is no treatment available for the disease. However, there
are few diagnostic tests available in the market which are the only saving
grace for the global mitochondrial myopathy diagnosis and treatment market at
present. Research play a major role in the determining new diagnostic test and
treatment options for mitochondrial myopathy.
Increasing number of patients with mitochondrial
myopathy patients, development in the disease screening process and testing
services, availability of incentives for research in rare genetic diseases, and
government funding and support for the development of the treatment options.
However, the unavailability of treatment for rare genetic diseases, and lack of
awareness about the diagnosis of these diseases are major factors restraining
the growth of the market. Additionally, large portion of the population are
underdiagnosed due to lack of diagnostic methods also hinders the growth of the
market.
Key
players of Global Mitochondrial myopathies Market:
·
Reata
Pharmaceuticals, Inc.
·
Stealth
BioTherapeutics
·
Raptor
Pharmaceutical Corp.
·
GeneDx
·
NeuroVive
Pharmaceutical AB
Segments:
The
global mitochondrial myopathies market is segmented on the basis of type and
therapies. Based on type, the market has been segmented as Kearns-Sayre
syndrome (KSS), Leigh syndrome, Mitochondrial DNA depletion syndrome (MDS),
Mitochondrial encephalomyopathy, Mitochondrial neuro-gastrointestinal
encephalomyopathy (MNGIE), Myoclonus epilepsy with ragged red fibers (MERRF),
Neuropathy, ataxia and retinitis pigmentosa (NARP), Pearson syndrome,
Progressive external ophthalmoplegia (PEO). Based on the therapies, the market
has been segmented as dietary, supportive, vitamins, coenzymes and antioxidants
and other.
Regional
analysis
US
accounts for the maximum market share due to favorable reimbursement scenario and
greater expenditure on healthcare. Europe is the second largest market due to
large disposable income and rising awareness. Asia Pacific region is the
fastest region because of large unmet needs which is led by China and India.
The Middle East and Africa market is led by the gulf nations particularly Saudi
Arabia and UAE. The poor regions of Africa are expected to be a laggard due to
poor economic and political conditions.
Detailed Table
of Contents:
Table Of Contents
1. Introduction
1.1 Definition
1.2 Scope Of Study
1.2.1 Research Objective
1.2.2 Assumptions & Limitations
1.2.2.1 Assumptions
1.2.2.2 Limitations
1.3 Market Structure:
2. Research Methodology
2.1 Research Process:
2.2 Primary Research
2.3 Secondary Research:
3. Market Dynamics
3.1 Drivers
3.2 Restraints
3.3 Opportunities
3.4 Macroeconomic Indicators
4. Market Factor Analysis
4.1 Porters Five Forces Model
4.2 Bargaining Power Of Suppliers
4.3 Bargaining Power Of Buyers
4.4 Threat Of New Entrants
4.5 Threat Of Substitutes
4.6 Intensity Of Rivalry
...Continued
About US:
Market Research Future (MRFR), enable
customers to unravel the complexity of various industries through Cooked
Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research
Reports (3R), Continuous-Feed Research (CFR), and Market Research &
Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email:
sales@marketresearchfuture.com
No comments:
Post a Comment